MedTrace Logo

The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients

NCT05710159 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-03-01

No results posted yet for this study

Summary

The aims of this project are:

* to develop and implement a national multimodality application for patients with bladder cancer that builds upon knowledge from the iBLAD study.
* to investigate how the app, containing PRO questions on symptoms and QoL, information for health care providers, and peer-to-peer advice, can provide more knowledge on symptoms, QoL, and the need for supportive care.
* to examine the usability of and patient satisfaction with the app using qualitative methods.

Conditions

Interventions

DEVICE

iBLAD Application to monitor symptoms and quality of life by the use of pateint-reported outcomes

Development and implementation of a national multimodality application for patients with bladder cancer that builds upon knowledge from the iBLAD study.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Danish Cancer Society

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Helle Pappot, Professor · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-12
Primary Completion
2024-06-30
Completion
2024-12-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05710159 on ClinicalTrials.gov